Angiogenesis
New angiogenesis study results reported from Hiroshima University
Published in Women's Health Weekly, July 10th, 2008
According to recent research from Japan, " The aim of this study was to evaluate the potential role of UFT and its metabolite gamma-butyrolactone (GBL) for inhibition of angiogenesis induced by vascular endothelial growth factor (VEGF) in advanced cervical carcinoma by the determination of serum GBL and VEGF, and by immunohistochemical staining to assess VEGF protein expression, before and after UFT therapy. The subjects were 35 patients with an advanced cervical carcinoma and five healthy volunteers between 2002 and 2003 at Hiroshima University Hospital, under informed consent."
"The patients received two courses of oral fluoropyrimidine (UFT) therapy at a dose of 600...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Kaiser Permanente
Treatment for cigarette, alcohol and drug use in pregnancy improves outcomes for mom and baby - Radiological Society of North America
Simple ultrasound exam may predict osteoporosis risk - SAGE Publications
Ovarian cancer's specific scent detected by dogs - Weber Shandwick Worldwide
Improving university recruitment process may increase female surgical faculty, study finds - Acinar Cell Cancer
New acinar cell cancer study findings have been published by J.S. Reisfilho and colleagues - Angiogenesis
New angiogenesis study findings recently were reported by researchers at University of Antwerp - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
